News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acucela Inc. Appoints Former DuPont Merck Pharmaceuticals Scientist and Ophthalmic Expert, Ghanshyam Patil, Ph.D., as Vice President, Research & Development


3/1/2011 10:22:21 AM

SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage specialty pharmaceutical company focused on developing new treatments for blinding eye diseases, today announced that it has appointed Ghanshyam (Shyam) Patil, Ph.D. as Vice President, Research & Development. As a member of Acucela’s growing management team, Dr. Patil will be responsible for leading the direction of the Company’s early pipeline programs in retinopathy of prematurity, Stargardt disease and diabetic retinopathy, as well as evaluating new therapeutic areas for the Company.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES